Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Masters

Showing results (161-170 of 775) with videos related to

Pageof 78
Sort By:
Neurology|March 18, 2020
Total Aβ<sub>42</sub>/Aβ<sub>40</sub> ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosisJames D Doecke, Virginia Pérez-Grijalba, Noelia Fandos, et al.
Biochemical and Biophysical Research Communications|October 5, 2014
Design of non-aggregating variants of Aβ peptideJoanne M Caine, Quentin Churches, Lynne Waddington, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersYing Xia, Vincent Dore, Jurgen Fripp, et al.
Communicable Diseases Intelligence Quarterly Report|October 31, 2013
Surveillance for Creutzfeldt-Jakob disease in Australia: update to December 2012Genevieve M Klug, Alison Boyd, Teresa Zhao, et al.
Communicable Diseases Intelligence Quarterly Report|March 10, 2017
Creutzfeldt-Jakob disease surveillance in Australia: update to December 2015Genevieve M Klug, Alison Boyd, Shannon Sarros, et al.
The Journal of Biological Chemistry|January 29, 2005
The amyloid precursor protein (APP) of Alzheimer disease and its paralog, APLP2, modulate the Cu/Zn-Nitric Oxide-catalyzed degradation of glypican-1 heparan sulfate in vivoRoberto Cappai, Fang Cheng, Giuseppe D Ciccotosto, et al.
Journal of Neuropathology and Experimental Neurology|November 18, 2009
Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infectionVictoria Lewis, Andrew F Hill, Cathryn L Haigh, et al.
International Journal of Geriatric Psychiatry|March 29, 2021
Genetic testing in dementia-A medical genetics perspectiveAamira J Huq, Adrienne Sexton, Paul Lacaze, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 10, 2018
CSF Tau supplements 14-3-3 protein detection for sporadic Creutzfeldt-Jakob disease diagnosis while transitioning to next generation diagnosticsQiao-Xin Li, Shiji Varghese, Shannon Sarros, et al.
Biochemistry|February 20, 2002
A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processingAndreas Weidemann, Simone Eggert, Friedrich B M Reinhard, et al.
Pageof 78

Showing results (161-170 of 775) with videos related to

Sort By:
Pageof 78
Neurology|March 18, 2020
Total Aβ<sub>42</sub>/Aβ<sub>40</sub> ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosisJames D Doecke, Virginia Pérez-Grijalba, Noelia Fandos, et al.
Biochemical and Biophysical Research Communications|October 5, 2014
Design of non-aggregating variants of Aβ peptideJoanne M Caine, Quentin Churches, Lynne Waddington, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersYing Xia, Vincent Dore, Jurgen Fripp, et al.
Communicable Diseases Intelligence Quarterly Report|October 31, 2013
Surveillance for Creutzfeldt-Jakob disease in Australia: update to December 2012Genevieve M Klug, Alison Boyd, Teresa Zhao, et al.
Communicable Diseases Intelligence Quarterly Report|March 10, 2017
Creutzfeldt-Jakob disease surveillance in Australia: update to December 2015Genevieve M Klug, Alison Boyd, Shannon Sarros, et al.
The Journal of Biological Chemistry|January 29, 2005
The amyloid precursor protein (APP) of Alzheimer disease and its paralog, APLP2, modulate the Cu/Zn-Nitric Oxide-catalyzed degradation of glypican-1 heparan sulfate in vivoRoberto Cappai, Fang Cheng, Giuseppe D Ciccotosto, et al.
Journal of Neuropathology and Experimental Neurology|November 18, 2009
Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infectionVictoria Lewis, Andrew F Hill, Cathryn L Haigh, et al.
International Journal of Geriatric Psychiatry|March 29, 2021
Genetic testing in dementia-A medical genetics perspectiveAamira J Huq, Adrienne Sexton, Paul Lacaze, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 10, 2018
CSF Tau supplements 14-3-3 protein detection for sporadic Creutzfeldt-Jakob disease diagnosis while transitioning to next generation diagnosticsQiao-Xin Li, Shiji Varghese, Shannon Sarros, et al.
Biochemistry|February 20, 2002
A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processingAndreas Weidemann, Simone Eggert, Friedrich B M Reinhard, et al.
Pageof 78